NCT00140855View on ClinicalTrials.gov

A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 8, 2005

Primary Completion Date

April 18, 2007

Study Completion Date

July 1, 2007

Conditions
Synovial Sarcoma
Interventions
BIOLOGICAL

ipilimumab

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Medarex
All Listed Sponsors
collaborator

Medarex

INDUSTRY

lead

Ludwig Institute for Cancer Research

OTHER